ScieGen Pharmaceuticals, IncUsage: Quetiapine extended-release tablets are indicated for treating schizophrenia, acute episodes of bipolar I disorder (manic, mixed, depressive), and as adjunctive therapy for major depressive disorder. Pediatric indications require careful diagnostic evaluation and consideration of risks. Treatment should be integrated with psychological and social interventions.